Background: Recent work with long-term ethanol (EtOH) self-administration in nonhuman primate models has revealed a complex array of behavioral and physiological effects that closely mimic human alcohol abuse. Detailed neurophysiological analysis in these models suggests a myriad of preand postsynaptic neurobiological effects that may contribute to the behavioral manifestations of longterm EtOH drinking. The molecular mechanisms regulating presynaptic effects of this chronic EtOH exposure are largely unknown. To this end, we analyzed the effects of long-term EtOH self-administration on the levels of presynaptic SNARE complex proteins in Macaca mulatta basolateral amygdala, a brain region known to regulate both aversive and reward-seeking behaviors.
N ONHUMAN PRIMATE ETHANOL (EtOH) drinking models closely parallel many aspects of human alcohol use/misuse. These parallels include the enhanced vulnerability of late adolescent animals (Baker et al., 2017; Helms et al., 2014) and the ability of drinking behaviors during initial exposures to predict future consumption patterns (Baker et al., 2017) . Although the neurophysiological mechanisms controlling these behaviors are poorly appreciated at present, neurophysiological studies from the brain slices of long-term, EtOH-drinking and control monkeys reveal a variety of alterations to neurotransmitter systems that parallel extensive work in rodents. Notably, many of these alterations are region specific but involve changes to both postsynaptic function and presynaptic neurotransmitter release. For example, EtOH drinking by adult male cynomolgus macaques increases dopamine release in the nucleus accumbens but not dorsolateral striatum/putamen (Siciliano et al., 2015) . EtOH drinking likewise increases both the frequency and amplitude of spontaneous glutamatergic synaptic events in the orbitofrontal cortex (Nimitvilai et al., 2017) but appears to only up-regulate glutamate release in the putamen (Cuzon Carlson et al., 2011) . Data on GABAergic alterations following long-term drinking are more mixed with both increased and decreased GABA release reported in different brain regions (Cuzon Carlson et al., 2011; Pleil et al., 2016) . Potential molecular mechanisms governing these presynaptic effects of long-term EtOH exposure are currently unknown in nonhuman primates and have been less frequently explored in other models.
Recent work in the rat lateral/basolateral amygdala suggests that EtOH exposure robustly modulates presynaptic function at glutamatergic and GABAergic synapses. The lateral/basolateral amygdala serves as the primary input nucleus for the extended amygdala. It receives sensory-, cognitive-, and memory-related glutamatergic inputs from numerous brain regions. Glutamatergic principal neurons in this region project both to well-studied components of the extended amygdala during regulation of innate anxiety and conditioned fear and to cognitive-and reward-related brain regions during reward-seeking behaviors (Janak and Tye, 2015) . Principal neuron activity is tightly controlled by at least 2 populations of GABAergic interneurons that include "feedback" cells scattered throughout the nuclei and "feedforward" neurons found locally as well as concentrated with intercalated cell "islands" found along the lateral boundary (Palomares-Castillo et al., 2012) . Acute EtOH facilitates GABAergic synaptic function from these interneuron populations through distinct pre-("feedback") and postsynaptic ("feedforward") mechanisms (Silberman et al., 2008) . On the other hand, chronic EtOH reduces release probability from "feedforward" GABA synapses without altering presynaptic function at inputs from "feedback" interneurons (Diaz et al., 2011) . Chronic EtOH also dramatically up-regulates presynaptic glutamate release onto lateral/basolateral amygdala neurons but only at stria terminalis synapses coursing into the region along the medial boundary (Christian et al., 2013) . Recent work in this brain region shows that acute EtOH can modulate the recycling of presynaptic vesicles at glutamatergic presynaptic vesicles without dramatically altering basal release probability . This process involves a Munc13 proteins (see below; that likely reflects direct interactions between these proteins and EtOH (Das et al., 2013) . Other than the role of Munc13 proteins, the effects of either acute or chronic EtOH on presynaptic release machinery have not been extensively explored.
The core SNARE complex mediates vesicular release at all "fast" neurotransmitter release sites (Sudhof, 2013) . Critical components within the complex include the syntaxins, which act as T-SNARE proteins associated with the presynaptic plasma membrane, and the VAMP proteins (also called synaptobrevins), which are intrinsic vesicular proteins (V-SNARE) that directly bind to syntaxins to anchor synaptic vesicles to release sites. SNAP 25, a syntaxin-associated protein, and the complexins mediate these T-and V-SNARE interactions during the fusion process by acting as priming/ fusion cofactors. Importantly, proteomic analysis of orbitofrontal cortical samples identified significant increases in both the syntaxins and SNAP25 following long-term EtOH drinking by adult male monkeys (Nimitvilai et al., 2017 ). An ancillary although critical protein in this core complex is Munc18-1 which binds to and converts syntaxin to a "release-competent" form during the priming process.
PKC-dependent phosphorylation of Munc18-1 facilitates this conversion process (Wierda et al., 2007) . All of these proteins are widely expressed in the central nervous system although there is regional specificity for some isoforms. For example, VAMP1 has higher relative expression in thalamic, midbrain, and cerebellar structures compared to VAMP2 (Allen Brain Atlas; Allen Institute for Brain Science, 2017).
Like vesicular fusion, vesicular priming at presynaptic release sites is a highly orchestrated process mediated by numerous protein-protein interactions (James and Martin, 2013) . For example, Munc13 proteins mediate initial interactions between syntaxin and vesicle membrane-associated Rab3 GTPases via interactions with the Rab3-binding protein, RIM1a (Lu et al., 2006) . Munc13 proteins thus facilitate vesicle priming and stay associated with primed vesicles to modulate release via direct interactions with Munc18-1 and syntaxin. Munc13-1 is present in most synapses while Munc13-2 is more enriched in cortical structures (Augustin et al., 1999) . There is a mixed literature on exact role of Munc13-2 showing both dominant-negative and dominantpositive roles for vesicle priming depending upon the synapse and brain region (Breustedt et al., 2010; Chen et al., 2013; Rosenmund et al., 2002) . This disparity may reflect the relative expression and distinct roles of known splice variants for Munc13-2 that include the ubiquitous isoform (uMunc13-2), which closely resembles Munc13-1 in both form and function, and the brain-specific isoform (bMunc13-2), which replaces important priming-promoting regions of the protein with negative regulatory sequences.
In summary, previous neurophysiological studies on brain slices from EtOH-drinking monkeys and chronic EtOH-exposed rodents suggest that modulation of presynaptic neurotransmitter release is a common finding across these models, and there are suggestions that long-term EtOH drinking can shift the abundance of some SNARE-related proteins (Nimitvilai et al., 2017) . The purpose of the current work is to offer a more detailed examination of the impact of EtOH drinking in both male and female nonhuman primates on the relative expression of vesicle priming and release proteins. We focus these efforts on monkey lateral amygdala given the central role of this brain region in regulating emotional behaviors related to aversion and reward seeking.
MATERIALS AND METHODS

Tissue Samples
Lateral amygdala tissue samples were obtained from the Monkey Alcohol Tissue Research Resource (www.matrr.com; Daunais et al., 2014) . The dissections were performed using magnetic resonance imaging (MRI)-guided dissection (Daunais et al., 2010) . The brain was blocked into 4-mm slabs beginning at the rostral tips of the temporal poles. At the level of the caudal caudate/ putamen and globus pallidus internal and external segments, the amygdaloid complex is visible on the face of a single block. The lateral nucleus is clearly distinguished from surrounding structures in this complex; it is lateral and well ventral to the central nucleus and lateral to the basolateral/accessory basal nuclei which are clearly demarcated by robust white matter tracts within those subdivisions. Dissections thus stayed within the margin of the lateral nucleus. Male and female individuals from separate cohorts (females-cohorts 6a and 6b; males-cohorts 5 and 7a) chosen based on similar drinking experiences (below), ages of the individuals (4 to 6 years old at the beginning of the exposure), and broad representation of drinking phenotypes as defined previously for these cohorts (Baker et al., 2017) . These phenotypes included binge drinkers ("BD"), light drinkers ("LD"), heavy drinkers ("HD"), and very heavy drinkers ("VHD") which denote categorical classifications based on average daily intake (g/kg/d), stable intake patterns, and average blood alcohol concentration (BAC; mg/dl) . Experimentally na€ ıve animals within each cohort served as controls; they consumed the same diet and self-administered water and an isocaloric maltose-dextrin solution under identical operant conditions Grant et al., 2008) .
Long-term EtOH self-administration was established as previously described (Grant et al., 2008) . Briefly, monkeys experienced a 3-month-long induction period where banana-flavored food pellets were delivered on a fixed-time interval schedule along with the availability of water and then 4% (w/v) EtOH solution in water. Consumption was precisely limited such that total intake increased incrementally from 0.5 g/kg/d, 1.0 g/kg/d, and finally 1.5 g/kg/d over 30 consecutive days for each intake limit. Following this induction period, all cohorts were given 12 months of continuous access (22 h/d) of EtOH referred to as open-access self-administration. A period of 2 to 3 weeks followed the first 6 months of open access to allow for MRI brain imaging and endocrine assessment profiling where EtOH continued to be available, but the sessions were shortened to accommodate the repeated blood sampling during this time (Porcu et al., 2006) . The final 6 months of drinking was also followed by a period of shortened sessions for MRI and endocrine measures, and then a return to normal 22-hour open-access sessions at least 3 full weeks prior to necropsy. The drinking data from the combined 6 and 12 months of open-access self-administration as well as categorical classifications for individual animals are shown in Table 1 . BACs were determined from saphenous vein blood samples as previously described (Grant et al., 2008) .
Sample Preparation
Twenty milligram rhesus lateral amygdala tissue was homogenized in T-PER Tissue Protein Extraction Reagent (#78510; Thermo Fisher, Waltham, MA) containing protease (#P8340; Sigma, St. Louis, MO) and phosphatase inhibitors (P5726 and PP0040; Sigma) using brief sonication. Following 2-hour incubation on a rotisserie mixer at 4°C, samples were centrifuged at 15,0009g to isolate the supernatant. Protein yield was quantified using Pierce BCA protein assay kit (#PI23227; Thermo Fisher, St. Louis, MO). Optical densities from the BCA reaction were read on a SpectraMax 384 Plus Spectrophotometer and compared to known protein concentrations using SoftMax Pro Software (Molecular Devices, Sunnyvale, CA). Analysis of lateral amygdala samples was randomized across different sides of the brain in this study.
Western Analysis
Five to 15 lg of total protein was loaded onto 4 to 20% Criterion TGX 26-well precast gels (#567-1095; Bio-Rad, Hercules, CA) along with Precision Plus Protein Dual Xtra Standards (#161-0377; Bio-Rad), separated per manufacturer's recommendations in a BioRad Criterion Vertical Electrophoresis Cell. Samples were loaded in pseudorandom order with respect to control or EtOH drinking, and each gel contained representative cohorts from both sexes. Gels were transferred to nitrocellulose membrane using a semidry technique with a Thermo Fisher iBlot Gel Transfer Device and preassembled membrane stacks (#IB301001; Thermo Fisher, Waltham). After transfer, membranes were incubated in blocking buffer containing Tris-buffered saline, 0.05% Tween-20, and 5% nonfat milk or, for detection of phosphorylated proteins, Pierce ProteinFree TBS Blocking Buffer (#0037570; Thermo Fisher, Waltham) for 1 hour at room temperature with agitation. Subsequently, membranes were incubated with agitation at 4°C overnight in a 1% solution of blocking buffer containing primary antibody for specific protein targets (Table 2) . Following extensive rinsing in Tris-buffered saline/0.05% Tween-20, the membranes were exposed to peroxidase-labeled goat anti-rabbit or goat anti-mouse secondary antibody (#A4914 or #A8924, respectively; Sigma). Detection of bound secondary antibody was performed using SuperSignal West Dura Extended Duration Substrate Enhanced Chemiluminescence (#34076; Thermo Fisher, Waltham). To control for loading differences between samples, membranes were stripped with Restore Plus Western Blot Stripping Buffer (#46430; Thermo Fisher, Waltham) Voluntary intake represents total grams consumed during the entire 12-month, free-choice, open-access period ("gE"; see text). c Blood draws for BAC determinations were performed for approximately 7 hours into the drinking sessions as described previously (Vivian et al., 2001). d Drinking phenotype was defined by Grant and colleagues (2008) and denoted on the MATRR website. e Data for g/kg/d previously reported in Jimenez and colleagues (2015) .
and probed with mouse monoclonal antibody directed against bactin, 1:10,000 dilution (#MAB1501; Millipore, Burlington, MA), followed by peroxidase-labeled goat anti-mouse secondary antibody, 1:10,000 dilution. Immunoreactive band intensity was captured from digital images with sequential exposure durations using a Bio-Rad ChemiDoc XRS Imaging System and analyzed with Quantity One Analysis software (Bio-Rad). To normalize band intensity across different gels, band intensities within each sample were normalized to control samples within each sex and adjusted by simple algebraic scaling across different blots. Results are therefore reported as arbitrary units. Data are presented as mean AE SEM.
Statistical Analysis
Standard 2-way analysis of variance (ANOVA) was used to analyze effects of EtOH drinking on protein expression levels using drinking history (control or EtOH drinking across phenotypes) and sex (male or female) as the main factors. Bonferroni multiple comparison post hoc tests were used to define significant effects of drinking within each sex (GraphPad Prism; GraphPad Software Inc., La Jolla, CA). Using this data set, we also performed select comparisons between control and very heavy-drinking individuals to complement recent work showing that induction-phase consumption patterns predict the drinking phenotypes during free access (Baker et al., , 2017 and the identification of differentially methylated genes in the nucleus accumbens across these phenotypes which are related to synaptic plasticity including several presynaptic proteins (Cervera-Juanes et al., 2017a). We continued to use 2-way ANOVA across phenotype and sex as main factors along with Bonferroni multiple comparison post hoc tests. For correlational analyses with individual proteins, standard linear regressions were performed within sex for expression level versus drinking variable (see Results; GraphPad Prism). To identify specific drinking variables used in these correlations, Pearson product-moment analysis for the different drinking variables was used (SigmaPlot; Systat Software Inc., San Jose, CA). For correlations involving multiple proteins (see Results) , forward stepwise multiple regressions were performed within each drinking variable (SigmaPlot). For all analyses, p-values < 0.05 were considered significant.
RESULTS
Analysis of the Drinking Data
In our analysis of the drinking data, we focused on grams of EtOH voluntarily consumed across the experiment (total grams EtOH [gE]), daily average consumption (g/kg), and average BAC measured in samples taken 7 hours after the start of the daily session (BAC, mg/dl). In EtOH-drinking females (n = 11), Pearson product-moment analysis across these drinking variables indicated significant correlations between all 3 variables: gE and BAC (r = 0.901, p < 0.001); gE and average daily g/kg (r = 0.999, p < 0.001); and BAC and average daily g/kg (r = 0.889, p < 0.001). There were also significant correlations between all 3 variables in EtOHdrinking males (n = 16): gE and BAC (r = 0.830, p < 0.001); gE and average daily g/kg (r = 0.999, p < 0.001); and BAC and average daily g/kg (r = 0.829, p < 0.001). However, within the male drinkers, multiple linear regression analysis suggested that lifetime voluntary drinking strongly predicted average daily g/kg (p < 0.001) but not BAC (p ≫ 0.05). For this reason, we confined our subsequent correlation analysis between protein expression levels across both sexes to lifetime voluntary gE and BAC (mg/dl).
Vesicle Priming Proteins
We artificially divided presynaptic proteins into those primarily associated with vesicle priming and those more directly involved in vesicle release (see Fig. 5 ). We subsequently used 2-way ANOVA with sex and drinking history as the main factors to assess the effects of long-term EtOH drinking on protein expression levels. For priming proteins, there was no significant interaction between the main factors and no significant main effect for either sex or drinking for Rab3c, vGluT1, and vGluT2 (Fig. 1B,E,F) . However, for both Rab3a (F = 4.234, p < 0.05; Fig. 1A ) and Munc13-2 (F = 4.985, p < 0.05; Fig. 1D ), there was a significant main effect of EtOH drinking history in both sexes. This suggests that long-term EtOH drinking by rhesus macaques reduces the levels of these proteins relative to control monkeys. However, the effect sizes were relatively modest. Rab3a levels were reduced by only~10% in both sexes, and Munc13-2 levels were reduced by~10% in male EtOH drinkers and bỹ 23% in females. Bonferroni's multiple comparison posttest did not identify significant effects of EtOH drinking within either sex. In contrast to these significant main effects of EtOH drinking, there were significant main effects of sex for Munc13-1 (F = 15.94, p < 0.001; Fig. 1C ) with protein levels in female controls being~50% greater than that of male controls. Fig. 1 . Ethanol (EtOH) drinking and sex alter expression levels for some proteins involved in vesicle priming. Exemplar blots for each protein are shown beneath the bar graphs with approximate molecular weights of the target indicated to the left. "C" and "E" denote lateral amygdala samples prepared from nondrinking controls (also denoted as "CON") and EtOH drinkers (also "EtOH"), respectively. Protein expression level is denoted as "arbitrary units" (see Methods). Recent work with nonhuman primate tissues collected following long-term EtOH self-administrations suggests unique cellular and molecular effects within tissues isolated from individuals with distinct EtOH-drinking phenotypes (Cervera-Juanes et al., 2017a,b; Cuzon Carlson et al., 2011) . In the cohorts used in this study, VHD phenotypes are well represented among male and female drinkers (n = 6 and 7, respectively; Table 1 ). We therefore performed a selective comparison between control (CON) and VHD individuals across the proteins associated with vesicle priming (Table 3) . Expression of Rab3a, Munc13-2, vGluT1, and vGluT2 proteins yielded similar results to the 2-way analysis across all drinking phenotypes. However, comparisons of Rab3c and Munc13-1 protein levels within CON and VHD individuals revealed novel effects of long-term EtOH self-administration in VHD individuals. For Rab3c, there were novel and significant main effects of both sex (F = 9.41, p < 0.01) and VHD phenotype (F = 5.22, p < 0.05) but no significant interaction between factors (F = 1.39, p > 0.05). Bonferroni's multiple comparison tests across the CON and VHD groups revealed a significant decrease in Rab3c protein levels in females (~30% decrease, t = 2.43, p < 0.05) but not males (~8% decrease, t = 0.79, p > 0.05). The selective Munc13-1 analysis comparing CON and VHD individuals identified a significant difference in protein levels between males and females (F = 14.5, p < 0.001) in addition to a novel main effect of drinking in the VHD phenotype (F = 5.29, p < 0.05). Notably, these significant differences were not identified in the analysis combining all drinkers.
While EtOH drinking and sex had influenced expression levels for some proteins related to vesicle priming, it is also plausible that the relative expression levels of these proteins themselves contribute to drinking-related behaviors. We therefore performed correlation analysis between protein expression levels and both lifetime voluntary gE and BAC. We restricted our analysis to proteins with no main effect of EtOH drinking across all drinking phenotypes. In female drinkers (green lines, Fig. 2) , there was a modest negative correlation between the expression levels of Rab3c and voluntary EtOH consumption (g) during the experiment (R 2 = 0.4, F = 6.115, p < 0.05; Fig. 2A 1 ) . In male drinkers (red lines, Fig. 2 ), there were also modest negative correlations between the average BAC (mg/dl) during the 12-month drinking period and the expression levels of Munc13-1 (R 2 = 0.35, F = 7.48, p < 0.05; Fig. 2B 2 ) and vGluT2 (R 2 = 0.32, F = 6.598, p < 0.05; Fig. 2D 2 ). There were no significant correlations between vGluT1 protein levels and either voluntary consumption (gE) or BAC in either sex. These data suggest modest associations between the relative levels of Rab3c, Munc13-1, and vGluT2 and either lifetime consumption in females (Rab3c) or BAC in males (Munc13-1 and vGluT2). Correlational analysis between protein expression and drinking variables for proteins involved in vesicle priming. Correlations were performed between protein expression levels (arbitrary units) and lifetime ethanol (EtOH) intake during the voluntary consumption periods (in grams, left column; see Methods) or average blood alcohol concentration (BAC) (mg%; right column) only for those proteins without a significant main effect of EtOH drinking (Fig. 1) . Protein levels from male (red lines and symbols) and female samples (green lines and symbols) are shown separately. Statistically significant correlations are denoted by R 2 and p-values, and 90% confidence limits are indicated by the dashed lines. (A) Protein levels of Rab3c were significantly correlated (slope = À0.33 AE 0.13, F = 6.115) with total voluntary EtOH intake but not average BAC in females. (B) Munc13-1 protein expression levels were significantly correlated with average BAC (slope = À3.12 AE 1.14, F = 7.48) but not total voluntary intake in males. (C) There is no significant correlation between vGluT1 protein levels and either voluntary consumption or BAC. (D) vGluT2 protein levels are significantly correlated with BAC (slope = À27.2 AE 10.6, F = 6.6), but not EtOH intake, in lateral amygdala from male drinkers.
Fusion-Complex Proteins
With respect to proteins more directly involved in vesicle release, 2-way ANOVA revealed no significant interactions between the sex and EtOH drinking main factors for most of these proteins (Fig. 3) . However, using the ratio of S515-phosphorylated Munc18-1 to total Munc18-1 protein levels as a proxy "active" Munc18-1 (Sassa et al., 1996) , we found a trend for an interaction between EtOH drinking and sex (F = 4.079; p~0.06; Fig. 3A 3 ) with EtOH drinking tending to decrease levels in males and increase levels in females. There was a significant main effect of drinking history for complexin 2 (F = 7.03, p < 0.05; Fig. 3F ) and a trend for complexin 1 (F = 4.003, p~0.053; Fig. 3E ). Effect sizes were again modest with EtOH drinking decreasing complexin 2 levels by~12% in males and~17% in females with no significant differences between control and EtOH drinking in either sex (Bonferroni multiple comparison test, p > 0.05). We also found a significant main effect of sex for SNAP25 (F = 19.9, p < 0.001; Fig. 3D ) with females expressing higher levels than control males by~20%. There was no significant main effect across either factor for Munc18-1, VAMP1/2, or syntaxin 1 protein levels. Like priming-related proteins, these data suggest modest effects of EtOH drinking on complexin 2 and potentially complexin 1 and "active" Munc18-1. Our selective comparison of expression level for vesicle release proteins across CON and VHD animals again revealed potentially novel effects of EtOH drinking among those individuals with the highest consumption levels. For example, the CON/VHD comparison revealed a significant interaction between sex and phenotype for the VAMP2 protein (Table 3 ; F = 6.35, p < 0.05). Compared to controls, VAMP2 protein levels were significantly higher in male VHD individuals (~48%, t = 2.72, p < 0.05, Bonferroni's multiple comparison posttest) and lower in female VHDs (~15% inhibition, t = 0.90, p > 0.05). This analysis also found significant, novel main effects of the VHD phenotype for SNAP25 (F = 4.76, p < 0.05) and complexin 1 (F = 4.91, p < 0.05), but these effect sizes were modest (10 to 15% decrease relative to CON) and were not significant in the posttest. The CON/VHD comparison also revealed a novel and significant main effect of sex on complexin 2 protein levels (F = 4.76, p < 0.05) but no interaction between sex and drinking phenotype (F = 0.12, p > 0.05). Notably, the main effect of the VHD phenotype on complexin 2 that was also present in the analysis across the range of drinking phenotypes was now characterized by a significant decrease in protein levels in male (~21%, t = 2.58, p < 0.05, Bonferroni posttest) but not female VHD individuals (~15% inhibition, t = 1.96, p > 0.05). This selective comparison between controls and VHD EtOH animals did not find any significant effects on protein expression for Munc18-1, Ser515-phosphorylated Munc18-1, VAMP1, or syntaxin 1.
To examine associations between protein expression levels and drinking behaviors, we again performed correlations for individual proteins not significantly altered by drinking history. In female drinkers (green lines, Fig. 4 ), there were no significant correlations between any of the fusion-related proteins and either total voluntary consumption (gE) or BAC (mg/dl). However, in male drinkers (red lines, Fig. 4) , there was a significant positive correlation between total voluntary consumption and VAMP2 proteins levels (R 2 = 0.45, p < 0.01; Fig. 4D 1 ) as well as a modest negative correlation between BAC and syntaxin 1 protein levels (R 2 = 0.26, p < 0.05; Fig. 4F 2 ) .
Multiple Regression Analysis
Given that individual protein levels had some ability to predict total consumption or BAC within each of the sexes, we addressed whether combinations of proteins might together better predict drinking outcomes using a forward stepwise regression analysis. In male drinkers, a model containing only VAMP2 significantly contributed to the voluntary consumption data. This was also the only protein showing a significant relationship with drinking in the pairwise correlations as well. For the BAC data, however, a model combining Munc13-1, Munc18-1, and VAMP1 was significantly correlated with the average mg/dl measures (adjusted R 2 = 0.597, F = 8.396, p < 0.01). Both Munc13-1 and VAMP1, each with negative correlation coefficients, together comprised 84% of the predicative power, while Munc18-1, with a positive correlation coefficient, contributed the remaining 16%. This suggested a combination of lower Munc13-1 and VAMP1 protein levels, with modest contributions by higher Munc18-1 protein levels, predicted male BAC measured 7 hours into the drinking period. Notably, this Munc13-1/Munc18-1/VAMP1 linear model predicted BAC to a greater degree (higher R 2 ) than the individual proteins identified in the pairwise analysis (Munc13-1 and vGluT2; see Fig. 2) . A similar analysis in female drinkers showed that no combination of proteins reliably predicted BAC. For total voluntary consumption, however, only Rab3c was significantly correlated, consistent with the pairwise correlation analysis for individual proteins ( Fig. 2A 1 ) .
DISCUSSION
A summary of our findings across all the proteins examined in our study is shown in Fig. 5 . For synaptic vesicle docking/priming proteins (Fig. 5, left) , long-term EtOH selfadministration reduced the levels of both Rab3a and Munc13-2 in the lateral amygdala regardless of sex. Rab3 proteins are small, vesicle-associated GTPases that, in the GTP-bound form, coordinate juxtaposition of plasma membrane calcium channels with synaptic vesicles at release sites via coordination of a macromolecular complex consisting of Munc13 and channel-binding proteins, RIM, and RIM-BP (Sudhof, 2004 (Sudhof, , 2013 . Recent evidence suggests that Munc13-2 levels modulate both intrinsic release probability at glutamate synapses (Gioia et al., 2016) and the acute sensitivity of vesicle recycling pathways to EtOH . These distinct roles suggest that decreases in Munc13-2 in EtOH drinkers may facilitate presynaptic activity, while decreases in Rab3a levels may represent a compensatory down-regulation of priming/release mechanisms following long-term EtOH drinking. Notably, females express higher levels of Munc13-1 than males. Given that greater levels of Munc13-1 relative to other Munc13 proteins increase presynaptic neurotransmitter release at central synapses (Chen et al., 2013; Gioia et al., 2016) , increased Munc13-1 levels in females suggests they may have greater presynaptic function. Fig. 3 . Ethanol (EtOH) drinking and sex alter the expression of lateral amygdala proteins involved in presynaptic vesicle release. Notations for the exemplar blots are the same as for Fig. 1. (A) Total protein levels for Munc18-1 (A 1 ) and for Munc18-1 phosphorylated on Ser515 (A 2 ) were not significantly altered by either sex or EtOH drinking. However, when "active" Munc18-1 was calculated as the ratio between p-Ser 515 Munc18-1 divided by total Munc18-1 (A 3 ), there was a trend for an interaction between the EtOH drinking and sex main factors. (B and C) No significant effect of either sex or EtOH drinking on VAMP1 or VAMP2 protein levels. (D) SNAP25 protein levels were significantly higher in female lateral amygdala samples compared to male samples (2-way ANOVA, p < 0.001 across the sex main factor). (E and F) EtOH drinking significantly reduced protein levels for complexin 2 (p < 0.05) with a trend for complexin 1 levels. (G) No significant effect of either sex or EtOH drinking on syntaxin 1 protein levels in lateral amygdala samples.
We also note however that there was a significant cohort effect in EtOH -drinking males (cohorts 5 and 7a) for the Rab3a data. Given cohort effects were not consistently present across all proteins with significant main effects of EtOH drinking, it is likely any cohort-related differences in Rab3a levels represent the differential distribution of categorical drinking phenotypes across these cohorts (Table 1) .
For proteins directly involved in vesicle release (Fig. 5,  right) , an EtOH drinking history reduces protein levels of both complexin 1 and complexin 2, again regardless of sex. These proteins facilitate calcium-dependent neurotransmitter release by stabilizing interactions between core SNARE complex proteins to promote priming (Trimbuch and Rosenmund, 2016; Xue et al., 2008) , but this stabilization also appears to reduce spontaneous release (Huntwork and Littleton, 2007) . Given that chronic EtOH exposure in rodents facilitates presynaptic function at lateral/basolateral glutamate synapses, and this facilitation is characterized by both increased calcium-dependent release (Christian et al., 2013) and enhanced spontaneous release (Lack et al., 2007) , complexin down-regulation may be a compensatory effect of long-term EtOH exposure (Lack et al., 2007) . Presynaptic modulation at GABAergic synapses in the lateral/basolateral amygdala is less well documented (but see below) although chronic EtOH can down-regulate GABA release at some synapses (Diaz et al., 2011) which typically express a relatively high frequency of spontaneous neurotransmission. It is also notable that we found that females express higher levels of SNAP25 compared to males. SNAP25 is a central component of the core SNARE complex and is intimately involved in presynaptic release for a wide variety of neurotransmitters including acetylcholine, glutamate, and GABA. SNAP25 increases the clustering of syntaxin at the plasma membrane, facilitates vesicle recruitment to release sites, and regulates the size of the pool of synaptic vesicles (Nagy et al., 2002 (Nagy et al., , 2004 Sorensen et al., 2003; Toft-Bertelsen et al., 2016) . Like our findings with Munc13-1, these observations suggest females may express greater capacity for release within presynaptic compartments.
Our correlational analysis examined only proteins without any treatment effects across the entire population of EtOH drinkers. These results suggest that proteins with significant relationships represent potentially heritable phenotypes contributing to specific aspects of drinking phenotype. In females, for example, the only significant correlation was between Rab3c and total voluntary consumption with lower expression levels predicting higher intakes. Like Rab3a, Rab3c is abundant in the central nervous system (Cheng et al., 2002) where it has been localized to both glutamatergic and GABAergic terminals (Bragina et al., 2011) , oligodendrocytes (Madison et al., 1996) , and secretory endocrine tissue (Iezzi et al., 1999) . However, it is noteworthy that our selective analysis between controls and VHD females also found significant effects of EtOH drinking Rab3c among this category of individuals that was not significant when including all phenotypes. This suggests that these particular correlations may have been substantially influenced by the decrease in Rab3c protein levels among VHD females. Given the relatively poor representation of HD and LD phenotypes in female drinkers for these specific cohorts, correlations within this sex should be interpreted with caution given potential confounds related to the "overrepresentation" of VHD female samples. In males, VAMP2 was the only protein correlated with total voluntary consumption with higher levels predicting higher consumption. VAMP2 levels are also correlated with dementia duration in Lewy-body disorder, Parkinson's disease, and Alzheimer's disease (Vallortigara et al., 2016) , and reduced levels of VAMP2 are found in transgenic mice that overexpress amyloid precursor protein (Pham et al., 2010) . Notably, exposure of hippocampal neurons to amyloid-b peptide reduces presynaptic glutamate release in vitro via modulation of VAMP2 levels (Hu et al., 2015) . These data suggest that positive relationships between VAMP2 levels and EtOH intake in males may reflect an EtOH-dependent up-regulation of vesicle release in this sex. A more complex picture emerged for relationships between SNARE protein levels and BACs. In the current study, blood samples were taken every 5 to 7 days throughout the 12-month drinking period but only at 7 hours after session onset. Thus, BAC itself may be a phenotypic proxy for drinking patterns. First, only male BACs were significantly correlated with any protein's expression level. Individually, syntaxin 1 and vGluT2 were each negatively correlated with average BAC, again suggesting that individual differences in neurotransmitter release from presynaptic compartments dictate individual drinking patterns. Interestingly, a multiple regression model containing expression levels of Munc13-1, Munc18-1, and VAMP1 proteins was correlated with BAC to a greater degree than individual proteins. This suggests that the overall function of the SNARE complex is a better predictor of individual drinking.
There have been no studies to date on the synaptic neurophysiology of lateral amygdala in monkeys, so integration of our expression analysis with the neurophysiological effects of EtOH drinking must be made in the context of other brain regions. For the glutamate system, chronic self-administration generally increases presynaptic function. This includes reports of increased frequency of miniature/ spontaneous glutamatergic excitatory postsynaptic currents (EPSCs) recorded from both putamen medium spiny neurons and insular cortical neurons (Alexander et al., 2012; Cuzon Carlson et al., 2011) in male macaques and in the insular cortex where EtOH drinking increased apparent glutamate release probability as indicated by synaptic responses to pairs of juxtaposed electrical stimuli (Alexander et al., 2012) . Similar findings have also been reported in the recordings from orbitofrontal cortical neurons of adult male cynomolgus macaques with an EtOH drinking history (Nimitvilai et al., 2017) . Notably, the increased frequency of miniature EPSCs in the putamen was also associated with an increase in spine density suggesting increased numbers of synapses in EtOH drinkers as a potential mechanism (Cuzon Carlson et al., 2011) . These data are consistent with a growing literature in rodents showing increased presynaptic glutamatergic function following chronic EtOH exposure (Christian et al., 2013; Lack et al., 2007; Morales et al., 2018; Sabria et al., 2003) . Similar to these glutamate observations, total lifetime intake by EtOH-drinking female macaques was positively correlated with dopamine release in the nucleus accumbens (Siciliano et al., 2016) . The effects of EtOH drinking on GABAergic presynaptic function are less frequent and include both increased (Pleil et al., 2016) and decreased (Cuzon Carlson et al., 2011) release in distinct brain regions. Given the paucity of data related to the neurophysiological effects of EtOH drinking in macaques, the rich literature in rodents highlighting region-specific alterations in synaptic function points toward a similar diversity in nonhuman primates.
In summary, we found that an extensive history of EtOH self-administration in rhesus macaques altered expression of a number of proteins participating in presynaptic neurotransmitter release and vesicle priming/recycling. These alterations were protein dependent and occurred independently in both male and female drinkers. Correlational analysis revealed significant proportional associations between proteins levels and aspects of EtOH intake BAC during the open-access self-administration for several proteins or groups of proteins. Given these proteins were not significantly altered by the EtOH self-administration across the drinking population, it is possible that individual differences in expression levels for these SNARE complex components represent potentially heritable phenotypes related to neurotransmitter homeostasis or release, and these phenotypes contribute both to total consumption and potentially to patterns of intake.
